According to a new market report published by Persistence Market
Research “Global Market Study on Membrane Technology in
Pharmaceutical, Biopharma and Life Sciences: North America to Witness
Highest Growth by 2019” the global membrane
technology market for pharmaceutical, biopharma and life sciences
is estimated at USD 7,029.9 million in 2014 and is expected to grow
at a CAGR of 9.1% from 2014 to 2019, to reach an estimated value of
USD 10,886.0 million in 2019.
North America is the largest market for membrane technology in
pharmaceutical, biopharmaceutical and life sciences industries. The
U.S. is the world’s largest market for pharmaceutical and
biopharmaceutical products. According to the European Federation of
Pharmaceutical Industries and Associations, North America accounted
for about 41% of global pharmaceutical sales in 2012.
Similarly, in Europe, membrane technology is a rapidly growing sector
with many associations, organizations and societies actively involved
in expansion and implementation of this technology in various
industries including pharmaceutical, biopharmaceutical and life
sciences.
However, Asia is the fastest growing region in the membrane
technology market due to continuous development in pharmaceutical and
biopharmaceutical industries.
Checkout page @
GE Healthcare Life Sciences and 3M are some of the leading players in
the global membrane technology market in pharmaceutical, biopharma
and life sciences. Other major players of the membrane technology
market include Pall Corporation, Sartorius, Merck Millipore, Koch
Membrane Systems Inc., Novasep, TriSep Corporation, Amazon Filters
Ltd. and Advantec MFS.
No comments:
Post a Comment